Microscopic colitis (MC) has been recognized as a chronic inflammatory bowel disease and a common cause of chronic, non-bloody diarrhea. The diagnosis rests on specific histological findings in colonic biopsies from patients with chronic diarrhoea demonstrating either lymphocytic colitis (LC) or collagenous colitis (CC). Proper diagnosis and regular follow-ups are important to differentiate these patients from those with irritable bowel syndrome (IBS), to provide relevant treatment, and to improve quality of life. Our knowledge about MC is still limited and more research is needed to further investigate the aetiology and pathophysiology of MC and to improve the clinical management and care of MC patients.
The European Microscopic Colitis Group (EMCG) has been found in Stockholm in 2010 by a small group of dedicated physicians and clinical researchers from 3 countries. The primary objectives of the EMCG are to create awareness on MC among patients, general practitioners, gastroenterologists, surgeons, and pathologists and to promote scientific collaborations in clinical trials and basic science.
In October 2015, the EMCG is celebrating its 5th anniversary. In those years the group has grown extensively and currently includes over 25 active members from 10 European countries. Since 2010, the EMCG has achieved important milestones such the publication of an Expert Statement Paper and the recognition by other European societies such as ECCO and UEG. Most recently the EMCG has been granted the UEG Link Award for the establishment of a European registry, in order to gain more insights in the long-term disease course and treatment related aspects and to harmonize the clinical management of microscopic colitis across Europe.
The EMCG welcomes clinical researchers and young scientists who have a special interest in microscopic colitis.